BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25399948)

  • 1. Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).
    Dreyer ZE; Hilden JM; Jones TL; Devidas M; Winick NJ; Willman CL; Harvey RC; Chen IM; Behm FG; Pullen J; Wood BL; Carroll AJ; Heerema NA; Felix CA; Robinson B; Reaman GH; Salzer WL; Hunger SP; Carroll WL; Camitta BM
    Pediatr Blood Cancer; 2015 Mar; 62(3):419-26. PubMed ID: 25399948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.
    Pieters R; De Lorenzo P; Ancliffe P; Aversa LA; Brethon B; Biondi A; Campbell M; Escherich G; Ferster A; Gardner RA; Kotecha RS; Lausen B; Li CK; Locatelli F; Attarbaschi A; Peters C; Rubnitz JE; Silverman LB; Stary J; Szczepanski T; Vora A; Schrappe M; Valsecchi MG
    J Clin Oncol; 2019 Sep; 37(25):2246-2256. PubMed ID: 31283407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.
    Hilden JM; Dinndorf PA; Meerbaum SO; Sather H; Villaluna D; Heerema NA; McGlennen R; Smith FO; Woods WG; Salzer WL; Johnstone HS; Dreyer Z; Reaman GH;
    Blood; 2006 Jul; 108(2):441-51. PubMed ID: 16556894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group.
    Tomizawa D; Koh K; Hirayama M; Miyamura T; Hatanaka M; Saikawa Y; Ishii E
    Pediatr Blood Cancer; 2009 Jul; 52(7):808-13. PubMed ID: 19229974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.
    Kosaka Y; Koh K; Kinukawa N; Wakazono Y; Isoyama K; Oda T; Hayashi Y; Ohta S; Moritake H; Oda M; Nagatoshi Y; Kigasawa H; Ishida Y; Ohara A; Hanada R; Sako M; Sato T; Mizutani S; Horibe K; Ishii E
    Blood; 2004 Dec; 104(12):3527-34. PubMed ID: 15297313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium.
    Silverman LB; McLean TW; Gelber RD; Donnelly MJ; Gilliland DG; Tarbell NJ; Sallan SE
    Cancer; 1997 Dec; 80(12):2285-95. PubMed ID: 9404706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96).
    Isoyama K; Eguchi M; Hibi S; Kinukawa N; Ohkawa H; Kawasaki H; Kosaka Y; Oda T; Oda M; Okamura T; Nishimura S; Hayashi Y; Mori T; Imaizumi M; Mizutani S; Tsukimoto I; Kamada N; Ishii E
    Br J Haematol; 2002 Sep; 118(4):999-1010. PubMed ID: 12199778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group.
    Tomizawa D; Kato M; Takahashi H; Fujimura J; Inukai T; Fukushima T; Kiyokawa N; Koh K; Manabe A; Ohara A
    Int J Hematol; 2015 Nov; 102(5):602-10. PubMed ID: 26410102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.
    Dreyer ZE; Dinndorf PA; Camitta B; Sather H; La MK; Devidas M; Hilden JM; Heerema NA; Sanders JE; McGlennen R; Willman CL; Carroll AJ; Behm F; Smith FO; Woods WG; Godder K; Reaman GH
    J Clin Oncol; 2011 Jan; 29(2):214-22. PubMed ID: 21135279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia.
    Koh K; Tomizawa D; Moriya Saito A; Watanabe T; Miyamura T; Hirayama M; Takahashi Y; Ogawa A; Kato K; Sugita K; Sato T; Deguchi T; Hayashi Y; Takita J; Takeshita Y; Tsurusawa M; Horibe K; Mizutani S; Ishii E
    Leukemia; 2015 Feb; 29(2):290-6. PubMed ID: 24888273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407.
    Salzer WL; Jones TL; Devidas M; Hilden JM; Winick N; Hunger S; Carroll WL; Camitta B; Dreyer ZE
    Pediatr Blood Cancer; 2012 Nov; 59(5):834-9. PubMed ID: 22488662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
    Pui CH; Behm FG; Downing JR; Hancock ML; Shurtleff SA; Ribeiro RC; Head DR; Mahmoud HH; Sandlund JT; Furman WL
    J Clin Oncol; 1994 May; 12(5):909-15. PubMed ID: 8164041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study.
    Mann G; Attarbaschi A; Schrappe M; De Lorenzo P; Peters C; Hann I; De Rossi G; Felice M; Lausen B; Leblanc T; Szczepanski T; Ferster A; Janka-Schaub G; Rubnitz J; Silverman LB; Stary J; Campbell M; Li CK; Suppiah R; Biondi A; Vora A; Valsecchi MG; Pieters R;
    Blood; 2010 Oct; 116(15):2644-50. PubMed ID: 20592248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group.
    Tomizawa D; Koh K; Sato T; Kinukawa N; Morimoto A; Isoyama K; Kosaka Y; Oda T; Oda M; Hayashi Y; Eguchi M; Horibe K; Nakahata T; Mizutani S; Ishii E
    Leukemia; 2007 Nov; 21(11):2258-63. PubMed ID: 17690691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
    Lu XT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.
    Kang H; Wilson CS; Harvey RC; Chen IM; Murphy MH; Atlas SR; Bedrick EJ; Devidas M; Carroll AJ; Robinson BW; Stam RW; Valsecchi MG; Pieters R; Heerema NA; Hilden JM; Felix CA; Reaman GH; Camitta B; Winick N; Carroll WL; Dreyer ZE; Hunger SP; Willman CL
    Blood; 2012 Feb; 119(8):1872-81. PubMed ID: 22210879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group.
    Salzer WL; Jones TL; Devidas M; Dreyer ZE; Gore L; Winick NJ; Sung L; Raetz E; Loh ML; Wang CY; De Lorenzo P; Valsecchi MG; Pieters R; Carroll WL; Hunger SP; Hilden JM; Brown P
    Pediatr Blood Cancer; 2015 Mar; 62(3):414-8. PubMed ID: 25407157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results from the Japan Infant Leukemia Study Group.
    Nagayama J; Tomizawa D; Koh K; Nagatoshi Y; Hotta N; Kishimoto T; Takahashi Y; Kuno T; Sugita K; Sato T; Kato K; Ogawa A; Nakahata T; Mizutani S; Horibe K; Ishii E;
    Blood; 2006 Jun; 107(12):4663-5. PubMed ID: 16478880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.
    Chijimatsu I; Imanaka Y; Tomizawa D; Eguchi M; Nishimura S; Karakawa S; Miki M; Hamamoto K; Fujita N
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28675638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
    Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
    Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.